Pantoprazol Ever Pharma (Pantoprazole)

Pantoprazol Ever Pharma is a proton pump inhibitor that acts on the gastric acid secretion pathway.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Adverse reactions reported with pantoprazole intravenous administration are generally mild to moderate.

Common Side Effects

• Headache: mild and transient.
• Diarrhoea: loose stools without blood.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the upper abdomen.
• Injection site reactions: redness or mild swelling at the infusion site.

Serious or Rare Side Effects

• Severe hypersensitivity: rash, itching, swelling, or anaphylaxis.
• Clostridioides difficile infection: persistent watery diarrhoea.
• Acute interstitial nephritis: sudden decrease in kidney function.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Thromboembolic events: deep vein thrombosis or pulmonary embolism.

When using Pantoprazol Ever Pharma, consider the following safety measures:

• Renal impairment: dose adjustment may be needed in severe kidney dysfunction.
• Hepatic impairment: monitor liver function tests in patients with liver disease.
• Elderly patients: observe for increased sensitivity to side effects.
• Concomitant use with NSAIDs: higher risk of gastrointestinal bleeding.
• Pregnancy and lactation: weigh benefits against potential risks; use only if clearly indicated.
• Store at below 25°C: keep in the original container, protect from moisture and light.

Pantoprazol Ever Pharma may interact with several medicines that share metabolic pathways or affect gastric pH.

Major Interactions (Avoid)

• Ketoconazole oral suspension: reduced absorption due to increased gastric pH.
• Atazanavir: markedly decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR values.
• Methotrexate: increased serum levels, especially at high doses.
• Digoxin: modest increase in serum concentration.